NRIX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Insider Trading Summary & Commentary
Automated executive transaction analysis for NRIX
Over the last 90 days, corporate insiders at NRIX (NRIX) engaged in a total of 90 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 51 were sales. The total volume of insider trading reached $6.32M.
The net insider activity for NRIX shows a net selling bias of $6.32M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Ring Christine (GC), who traded 37.6K shares valued at $642K on Nov 24, 2025.
Live Market News & Developments
Aggregated real-time headlines for NRIX (NRIX)
6 updates
Nurix Therapeutics, Inc. (NRIX) stock price, news, quote and history
Yahoo Finance Australia2d ago
Nurix Therapeutics Stock Price Forecast. Should You Buy NRIX?
StockInvest.us2d ago
Nurix Therapeutics stock hits 52-week low at $13.64 By Investing.com
Investing.com UK22h ago
Why Nurix Therapeutics (NRIX) stock is down today
TradingView16d ago
NRIX Stock Clocks Worst Day Ever After Sanofi Discontinues Trial Of Licensed Drug: Wells Fargo Slashes Price Target
Yahoo Finance16d ago
Nurix Therapeutics: 'Strong Buy' Due To Roche Deal And Bexobrutideg Expansions
Seeking Alpha164d ago
FAQs About NRIX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for NRIX.
Based on SEC Form 4 disclosures, the Insider Confidence Score for NRIX is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 51 sales by company executives over the last 90 days.
The CEO Conviction Index for NRIX is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.
No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.